Centro Nacional de Microbiología (CNM)

Permanent URI for this collectionhttps://hdl.handle.net/20.500.12105/19609

El Centro Nacional de Microbiología (CNM) es uno de los centros pertenecientes al Instituto de Salud Carlos III que proporciona apoyo científico-técnico a la Administración General del Estado, a las Comunidades Autónomas y al Sistema Nacional de Salud (SNS), tal y como se recoge en La Ley General de Sanidad (Ley 14/1986, de 25 de abril) y el Estatuto del Instituto de Salud Carlos III (RD 375/2001, de 6 abril y su posterior reforma, RD 1672/2009, de 6 de noviembre). La función específica del CNM es el control de las enfermedades infecciosas para lo que ofrece servicios de diagnóstico y referencia, manteniendo además programas de investigación, tanto básica como orientada, relacionados con la prevención, el diagnóstico y el tratamiento de estas enfermedades. Dispone de un sistema de gestión de calidad conforme a la norma UNE-EN ISO 9001, certificado por AENOR, para la recepción de muestras biológicas, así como varias técnicas y servicios acreditados por ENAC según la norma UNE-EN ISO 15189.

Browse

Recent Submissions

Now showing 1 - 20 of 2052
  • Item type: Publication ,
    Towards symbiont-based visceral leishmaniosis control: Delftia tsuruhatensis TC1 shows anti-Leishmania infantum effect in Phlebotomus perniciosus
    (Frontiers Media, 2026-10-30) López-de-Felipe, Marcos; Jimenez, Maribel; Pérez-Martínez, Eva; Molina, Ricardo; Castañeda-Casado, Pablo; Lelièvre, Joel; Martin-Martin, Ines; Rodrigues, Janneth; GlaxoSmithKline; Instituto de Salud Carlos III
    Introduction: Visceral leishmaniosis caused by Leishmania infantum is a grave disease solely transmitted by vector sand flies with a high risk of mortality when left untreated. The introduction of symbiont bacteria with anti-parasitic properties within vector species represents a promising biological control strategy for vector-borne diseases. In this context, the symbiont bacterium Delftia tsuruhatensis strain TC1 (TC1) has previously demonstrated an in vivo antiparasitic effect in the sand fly Phlebotomus duboscqi against Leishmania major, the causative agent of cutaneous leishmaniosis. The current research aims to evaluate the anti-L. infantum effect of TC1 within Phlebotomus perniciosus, a major vector of visceral leishmaniosis in Southern Europe.Methods: Newly emerged Ph. perniciosus females were fed on a sugar meal spiked with TC1. Bacterial midgut colonization was evaluated through plating at different time points after bacteria ingestion in selective media and molecularly verified. TC1-fed sand flies were offered an L. infantum infectious blood meal 24 h after spiked-sugar was removed. The anti-L. infantum effect of TC1 was evaluated by quantifying the number of parasites per midgut and evaluating the infection rate of the stomodeal valve in comparison with control groups. Additionally, the anti-L. infantum effect of TC1 cell-free supernatant and harmane, a β-carboline alkaloid secreted by TC1 and previously reported to display in vitro anti-leishmanial activity, were evaluated in vitro through dose-response curves assays and by quantification of promastigotes within the midgut of sand flies. Leishmania infantum viscerotropic strains were used during assays.Results: TC1 was confirmed to colonize and persist within the midgut of female Ph. perniciosus up to at least 21 days after ingestion. TC1-fed sand flies showed a decrease in the number of promastigotes per midgut, as well as a reduction in the infection rate of the stomodeal valve. Both harmane and TC1-supernatant showed an anti-L. infantum effect under in vitro conditions, although no reduction in parasite counts was detected within sand flies.Discussion/conclusion: TC1 reduces the proliferation and development of L. infantum within the vector Ph. perniciosus. Our results show the potential of TC1 as a promising tool for controlling L. infantum in visceral leishmaniosis endemic areas in the future.
  • Item type: Publication ,
    Large Increase in Azithromycin-Resistant in Northern Spain.
    (SAGE Publishing, 2022-01) Carballo, Raquel; Povoa, Maria Clara; Abad, Raquel; Navarro Rivas, Carmen; Martin-Martin, Ines; Alvarez, Maximiliano; Salgado, Angel; Potel, Carmen; Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
    The aim of this study was to characterize the evolution of gonorrhea in the general population by correlating epidemiological, genotypic, and antimicrobial resistance data of isolates collected in northern Spain from 2014 to 2018. One hundred ninety-four strains underwent antimicrobial susceptibility testing and were genetically analyzed by multiantigen sequence typing. Increasing cases of gonococcal infections have been observed after 2015. Most occurred in male with urethritis. Sequence type (ST)-9972 and ST-1576, the predominant genotypes identified, have not been previously described as epidemic clones. Of great concern was the significant increase in azithromycin-resistant . More than 30% of these isolates were obtained from men who have sex with men (MSM). ST-12302 was the most prevalent clone among the azithromycin-resistant strains, and was also resistant to penicillin, ciprofloxacin, and tetracycline. This multidrug-resistant clone was exclusively isolated from MSM during 2018. The incidence rates of gonorrhea and azithromycin-resistant have significantly increased due to the emergence of new clones. ST-12302 has recently been recognized as an epidemic clone; therefore, its surveillance could be the key in controlling further dissemination of azithromycin resistance. These data highlight the need to perform local studies to update treatment guidelines and reinforce preventive measures against gonorrhea.
  • Item type: Publication ,
    Aedes aegypti sialokinin facilitates mosquito blood feeding and modulates host immunity and vascular biology.
    (Elsevier, 2022-04-12) Martin-Martin, Ines; Valenzuela Leon, Paola Carolina; Amo, Laura; Shrivastava, Gaurav; Iniguez, Eva; Aryan, Azadeh; Brooks, Steven; Kojin, Bianca B; Williams, Adeline E; Bolland, Silvia; Ackerman, Hans; Adelman, Zach N; Calvo, Eric
    Saliva from mosquitoes contains vasodilators that antagonize vasoconstrictors produced at the bite site. Sialokinin is a vasodilator present in the saliva of Aedes aegypti. Here, we investigate its function and describe its mechanism of action during blood feeding. Sialokinin induces nitric oxide release similar to substance P. Sialokinin-KO mosquitoes produce lower blood perfusion than parental mosquitoes at the bite site during probing and have significantly longer probing times, which result in lower blood feeding success. In contrast, there is no difference in feeding between KO and parental mosquitoes when using artificial membrane feeders or mice that are treated with a substance P receptor antagonist, confirming that sialokinin interferes with host hemostasis via NK1R signaling. While sialokinin-KO saliva does not affect virus infection in vitro, it stimulates macrophages and inhibits leukocyte recruitment in vivo. This work highlights the biological functionality of salivary proteins in blood feeding.
  • Item type: Publication ,
    The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.
    (Elsevier, 2025-04) Shaw, David; Abad, Raquel; Amin-Chowdhury, Zahin; Bautista, Adriana; Bennett, Desiree; Broughton, Karen; Casanova, Carlo; Choi, Eun Hwa; Claus, Heike; Corcoran, Mary; Cottrell, Simon; Cunney, Robert; Cuypers, Lize; Dalby, Tine; Davies, Heather; de Gouveia, Linda; Deghmane, Ala-Eddine; Desmet, Stefanie; Domenech Lucas, Mirian; Drew, Richard; Plessis, Mignon du; Duarte, Carolina; Fuursted, Kurt; Golden, Alyssa; Almeida, Samanta Cristine Grassi; Henares, Desiree; Henriques-Normark, Birgitta; Hilty, Markus; Hoffmann, Steen; Humphreys, Hilary; Jacobsson, Susanne; Johnson, Christopher; Jolley, Keith A; Kawabata, Aníbal; Kozakova, Jana; Kristinsson, Karl G; Krizova, Pavla; Kuch, Alicja; Ladhani, Shamez; Lâm, Thiên-Trí; Ayala, María Eugenia León; Lindholm, Laura; Litt, David; Maiden, Martin C J; Martin, Irene; Martiny, Delphine; Mattheus, Wesley; McCarthy, Noel D; Meehan, Mary; Meiring, Susan; Mölling, Paula; Morfeldt, Eva; Morgan, Julie; Mulhall, Robert; Muñoz-Almagro, Carmen; Murdoch, David; Musilek, Martin; Novakova, Ludmila; Oftadeh, Shahin; Perez-Arguello, Amaresh; Perez-Vazquez, Maria; Perrin, Monique; Prevost, Benoit; Roberts, Maria; Rokney, Assaf; Ron, Merav; Sanabria, Olga Marina; Scott, Kevin J; Sempere, Julio; Siira, Lotta; de Lemos, Ana Paula Silva; Sintchenko, Vitali; Skoczyńska, Anna; Slotved, Hans-Christian; Smith, Andrew J; Taha, Muhamed-Kheir; Toropainen, Maija; Tzanakaki, Georgina; Vainio, Anni; van der Linden, Mark P G; van Sorge, Nina M; Varon, Emmanuelle; Vazquez-Moreno, Julio Alberto; Vohrnova, Sandra; von Gottberg, Anne; Yuste, Jose; Brueggemann, Angela B; Wellcome Trust; Ministry of Science and Higher Education (Polonia)
    Microbiology reference laboratories perform a crucial role within public health systems. This role was especially evident during the COVID-19 pandemic. In this Viewpoint, we emphasise the importance of microbiology reference laboratories and highlight the types of digital data and expertise they provide, which benefit national and international public health. We also highlight the value of surveillance initiatives among collaborative international partners, who work together to share, analyse, and interpret data, and then disseminate their findings in a timely manner. Microbiology reference laboratories have substantial impact at regional, national, and international levels, and sustained support for these laboratories is essential for public health in both pandemic and non-pandemic times.
  • Item type: Publication ,
    Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution.
    (Multidisciplinary Digital Publishing Institute (MDPI), 2025-06-13) Yuste, Eloisa; Ruiz-De-León, María J; Casado, José L; Moreno, Ana; Vivancos, María J; Pérez-Elías, María J; Dronda, Fernando; Quereda, Carmen; Sanchez-Merino, Victor; Vallejo, Alejandro; Instituto de Salud Carlos III
    Background/objectives: This study aimed to explore how HTLV-2 infection affects the production of broadly neutralizing antibodies (bNAbs) in persons with HIV-1 (PWH) and to assess the impact of boosted protease inhibitors (PIs). Methods: We evaluated broadly neutralizing antibody (bNAb) activity in 65 PWH, which included 27 who were also co-infected with HTLV-2. All participants were former injection drug users with HCV antibodies and were receiving suppressive antiretroviral therapy (ART). Neutralizing activity was assessed against six recombinant HIV-1 viruses that represent five different subtypes. B cell subsets were also analyzed. Results: HTLV-2 co-infection and the lack of ritonavir-boosted protease inhibitors (r-PIs) were both independently associated with higher neutralization scores (p = 0.017 and p = 0.005, respectively). Among those not on r-PIs, individuals co-infected with HTLV-2 showed significantly higher neutralization scores (p = 0.027) and a broader neutralization breadth (83.4% vs. 48.5%, p = 0.015) compared to those infected only with HIV-1. Additionally, HTLV-2 co-infected individuals had more resting memory B cells (p = 0.001) and fewer activated memory B cells (p = 0.017) than the HIV-1 mono-infected individuals. In our multivariate analysis, only HTLV-2 co-infection remained independently associated with neutralization scores (p = 0.027). Elite neutralizers (with a breadth score of ≥10) had more naive B cells and fewer resting memory B cells compared to those with weaker neutralization in both groups. Conclusions: Co-infection with HTLV-2 enhances bNAb production in PWH on suppressive ART and, in particular, in the absence of r-PI regimens. The prominent neutralizing activity corresponded with B cell subset distributions. The results suggest the complexity regarding the interaction between viral co-infections, antiretroviral regimens, and humoral immune compartments and may inform further H1V-1 pathogenesis inquiries or the appropriate design of a vaccine.
  • Item type: Publication ,
    Are mosquito species present in Spain competent for Oropouche virus?.
    (Springer Nature, 2026-06-05) Gutiérrez-López, Rafael; Labiod, Nuria; López-de-Felipe, Marcos; Sánchez-Mora, Patricia; Delacour-Estrella, Sarah; Martín-Ramírez, Alexandra; Potente, Arantxa; Pérez-Martínez, Eva; Molina, Ricardo; Sánchez-Seco, María Paz; Jimenez, Maribel; Vazquez, Ana; Martin-Martin, Ines; Centro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas); Instituto de Salud Carlos III; Ministerio de Educación (España); Ministerio de Ciencia e Innovación (España); Unión Europea. Comisión Europea. NextGenerationEU
    Background: Oropouche virus (OROV; Orthobunyavirus) is an emerging arbovirus endemic to South America and the Caribbean, with imported cases in European countries, including Spain. Although primarily transmitted by biting midges (Culicoides spp.), OROV has been detected in several mosquito species, raising concerns about potential establishment in nonendemic regions. European populations of Aedes albopictus, and Culex pipiens, as well as the invasive Aedes aegypti, represent relevant models for assessing vector competence. Objectives: Here, we evaluated the vector competence of Spanish Cx. pipiens biotype molestus, Spanish Ae. albopictus, and Ae. aegypti (Liverpool strain), for the 2024 OROV outbreak strain. Female mosquitoes were orally exposed to infectious blood meals and maintained under controlled insectary conditions at 27 °C. In addition, an additional group received a second noninfectious blood meal. The survival of the mosquitoes was monitored, and infection, dissemination, and transmission rates were assessed at 7, 14, and 21 days post infection. Vertical transmission of the virus to the progenies was also analyzed. Results: Overall, Ae. albopictus exhibited low infection rates, with occasional dissemination and transmission events. Aedes aegypti and Cx. pipiens biotype molestus showed infection and occasional dissemination, but no evidence of transmission. A second noninfectious blood meal did not significantly affect infection, dissemination, or transmission rates in any species. Viral loads in bodies and legs were low and did not differ significantly between species, time points, or feeding regimens. Survival was not affected by infection or blood-feeding regime. We did not find vertical transmission of OROV to the progenies. Conclusions: Regardless of virus dissemination in mosquitoes, our study indicates a poor vector competence of Spanish Ae. albopictus and no evidence of transmission under the conditions tested in Ae. aegypti and Cx. pipiens biotype molestus for the circulating OROV strain. These findings suggest a low risk for local OROV establishment in Spain, although continuous surveillance and research are warranted to monitor potential vector-virus adaptation.
  • Item type: Publication ,
    Meningococcal carriage in men who have sex with men presenting at a sexual health unit in Spain.
    (Springer Nature, 2023-03) Pérez-González, Alexandre; Carballo, Raquel; Araújo-Ameijeiras, Alejandro; Abad, Raquel; Navarro Rivas, Carmen; Ocampo, Antonio; Poveda, Eva; Potel, Carmen
    Neisseria meningitidis (Nm) is asymptomatically carried in the nasopharynx of 5-10% adults, although certain populations, such as men who have sex with men (MSM), exhibit a higher colonisation rate. Interest in Nm carriage has been renewed, owed to meningitis outbreaks within populations of MSM. The aim of this study was to characterise Nm isolates and risk factors for its carriage among MSM attending a sexual health unit. A retrospective cross-sectional study was undertaken between June 2018 and December 2021. We took anal, oropharyngeal, urethral, and blood samples as part of the sexually transmitted infection screening procedures routinely implemented. Nm isolates were subjected to antimicrobial susceptibility testing; the serogroup and genogroup were determined by multi-locus sequence typing. A total of 399 subjects were recruited, and the Nm oropharyngeal carriage rate was 29%, similar among both people living with HIV (PLWH) and uninfected individuals. Nm carriage was less common in vaccinated individuals, especially those who had received the tetravalent vaccine (2.6% vs. 10.6%, p = 0.008). The most frequent serogroups were B (40%) and non-groupable (45%). Most of the isolates were susceptible to ciprofloxacin (96%) and ceftriaxone (100%). However, we identified 21 strains (20%) belonging to hyperinvasive lineages (CC11, CC4821, CC32, CC41/44, CC213, and CC269), most of which belonged to serogroup B. Given that vaccination with MenACWY was associated with a low Nm carriage, we encourage routine vaccination of all MSM. Moreover, the administration of the meningitis B vaccine should also be assessed considering that several invasive lines included in serogroup B are circulating among MSM.
  • Item type: Publication ,
    Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare genosubtype (19-54, 15), Spain, March to April 2024.
    (European Centre for Disease Prevention and Control (ECDC), 2025-11) Abad, Raquel; Navarro Rivas, Carmen; Garcia-Amil, Cristina; Montes Mota, Marina; Castañeda-García, Alfredo; Cuadros, Juan A; Galar, Alicia; Martin, Fernando; Mena, Ester; Pérez de Madrid, Sara; Román, Carmen; Soler Soneira, Marta; Vazquez-Moreno, Julio Alberto
    In Spain during March-April 2024, an outbreak of invasive meningococcal disease (IMD) occurred in four young adults, exhibiting high case fatality with two deaths. Cases 1 and 4 were confirmed by isolation of from blood samples, while Cases 2 and 3 were PCR-confirmed from cerebrospinal fluid (CSF). Serogroup B meningococcus with identical characterisation (B: 19-54, 15: F5-1: ST-34, cc32) was identified for all cases; the outbreak strain genosubtype PorA_VR1: 19-54 had not been previously described. Potential coverage of the outbreak strain by available MenB vaccines could not be predicted by molecular tools, so bactericidal response to the 4CMenB vaccine against the outbreak strain was measured by human serum bactericidal antibody assay (hSBA), defining the strain as covered by the vaccine. Two different social events were involved in transmission of the outbreak strain. According to the national meningococcal disease surveillance protocol, an active search for close contacts of the cases was conducted by public health authorities and timely chemoprophylaxis and/or vaccination with 4CMenB vaccine was recommended to over 200 contacts. The evolution of meningococcal strains with genosubtype 19-54 should be closely monitored, as it might confer a greater transmission capacity.
  • Item type: Publication ,
    Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
    (Massachusetts Medical Society, 2023-02-02) Castilla, Jesús; García Cenoz, Manuel; Abad, Raquel; Sánchez-Cambronero, Laura; Lorusso, Nicola; Izquierdo, Conchita; Cañellas Llabrés, Soledad; Roig, Javier; Malvar, Alberto; González Carril, Fernando; Boone, An L.D.; Pérez Martín, Jaime; Rodríguez Recio, M. Jesús; Galmés, Antònia; Caballero, Arturo; García Rojas, Amós; Juanas, Felipe; Nieto, Mercedes; Viloria Raymundo, Luis J.; Martínez Ochoa, Eva; Rivas, Ana I.; Castrillejo, Daniel; Moreno Pérez, David; Martínez, Ana; Borràs, Eva; Sánchez Gómez, Amaya; Pastor, Eliseo; Nartallo, Victoria; Arteagoitia, José M.; Álvarez-Fernández, Blanca; García Pina, Rocío; Fernández Arribas, Socorro; Vanrell, Joana; García Hernández, Sara; Mendoza, Rita M.; Méndez, Manuel; López-Tercero, M. Mar; Fernández-Rodríguez, Ángela; Blanco, Ángela; Carrillo de Albornoz, F. Javier; Ruiz Olivares, José; Ruiz-Montero, Rafael; Limia, Aurora; Navarro-Alonso, José A.; Vazquez-Moreno, Julio Alberto; Barricarte, Aurelio
    Background: In September 2015, the four-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) became available for private purchase in Spain. Methods: We conducted a nationwide matched case-control study to assess the effectiveness of 4CMenB in preventing invasive meningococcal disease in children. The study included all laboratory-confirmed cases of invasive meningococcal disease in children younger than 60 months of age between October 5, 2015, and October 6, 2019, in Spain. Each case patient was matched with four controls according to date of birth and province. 4CMenB vaccination status of the case patients and controls was compared with the use of multivariate conditional logistic regression. Results: We compared 306 case patients (243 [79.4%] with serogroup B disease) with 1224 controls. A total of 35 case patients (11.4%) and 298 controls (24.3%) had received at least one dose of 4CMenB. The effectiveness of complete vaccination with 4CMenB (defined as receipt of at least 2 doses, administered in accordance with the manufacturer's recommendations) was 76% (95% confidence interval [CI], 57 to 87) against invasive meningococcal disease caused by any serogroup, and partial vaccination was 54% (95% CI, 18 to 74) effective. Complete vaccination resulted in an effectiveness of 71% (95% CI, 45 to 85) against meningococcal serogroup B disease. Vaccine effectiveness with at least one dose of 4CMenB was 64% (95% CI, 41 to 78) against serogroup B disease and 82% (95% CI, 21 to 96) against non-serogroup B disease. With the use of the genetic Meningococcal Antigen Typing System, serogroup B strains that were expected to be covered by 4CMenB were detected in 44 case patients, none of whom had been vaccinated. Conclusions: Complete vaccination with 4CMenB was found to be effective in preventing invasive disease by serogroup B and non-serogroup B meningococci in children younger than 5 years of age.
  • Item type: Publication ,
    Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy.
    (Oxford University Press, 2023-03-21) Berenguer, Juan; Jarrin Vera, Inmaculada; Bellón, José M; Díez, Cristina; Jimenez-Sousa, Maria Angeles; Roca, Cristina; González-García, Juan; Dalmau, David; Olalla, Julián; Herrero, Carmen; Villarroya, Francesc; Domingo, Pere; Resino, Salvador
    Background: We studied the association of obesity-related single-nucleotide polymorphisms (OR-SNPs) with weight gain after antiretroviral therapy (ART) in people with human immunodeficiency virus (HIV; PWH). Methods: Participants were ART-naive PWH from the Spanish HIV Research Cohort who started ART from 2014 onward and had blood/DNA deposited in the cohort Biobank. The primary outcome was change in weight at 96 weeks after starting ART. We genotyped 14 OR-SNPs from a meta-analysis of genome-wide association studies of body mass index (BMI) loci. Changes over time in weight and BMI were studied using adjusted linear mixed models. Results: A total of 1021 PWH were included. The mean weight gain over 96 weeks was 2.90 (95% confidence interval, 2.54-3.26) kg. Factors associated with higher weight gain were female sex, birth in sub-Saharan Africa, prior AIDS, CD4+ <200 cells/µL, HIV-RNA >100 000 copies/mL, negative hepatitis C virus serology, and use of tenofovir alafenamide. A significant association was found between ZC3H4 rs3810291 GG genotype and BCDIN3D/FAIM2 rs7138803 GG genotype polymorphisms and weight and BMI increase. The estimated adjusted mean (standard error [SE]) of weight gain was 4.26 (0.56) kg in ZC3H4 rs3810291 GG carriers and 2.66 (0.19) kg in AA/AG carriers (P = .007). Likewise the estimated weight gain at 96 weeks was 3.35 (0.29) kg in BCDIN3D/FAIM2 rs7138803 GG carriers and 2.51 (0.24) kg in AG/AA carriers (P = .020). Conclusions: Genetic factors may play a role in weight gain after ART initiation. Further work is needed to replicate our findings and understand how the identified SNPs lead to higher weight gain in this context.
  • Item type: Publication ,
    CCL5 Levels, Disease Progression, and Mortality in Respiratory Viral Infections: A Systematic Review and Meta-Analysis.
    (JAMA Network, 2026-08-03) Pita-Martínez, Carlos; Sepulveda-Crespo, Daniel; Bermejo-Martín, Jesús F; Martinez, Isidoro; Resino, Salvador; Centro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas); Instituto de Salud Carlos III; Unión Europea. Comisión Europea. NextGenerationEU
    Importance: The role of chemokine C-C motif ligand 5 (CCL5) in respiratory viral infections remains controversial; although essential for viral clearance, it is also implicated in pathogenic hyperinflammation. Objective: To quantify associations between CCL5 levels and unfavorable disease progression and mortality in respiratory viral infections. Data sources: Medline and PubMed, Embase, Scopus, Web of Science, the Cochrane Library, CABI Digital Library, and Global Health (Ovid) were searched from inception to October 1, 2025. Study selection: Observational studies evaluating the association of CCL5 levels with clinical severity or survival in patients with confirmed respiratory viral infections. Data extraction and synthesis: Two reviewers independently extracted data and assessed risk of bias (Newcastle-Ottawa Scale) and certainty of evidence (GRADE). Data were pooled using a random-effects model following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data analysis was performed from September 2025 to December 2025. Main outcomes and measures: Unfavorable disease progression (severity) and all-cause mortality. Results: The meta-analysis included 18 studies (2376 patients; median age, 58.2 [range, 0.08-65.0] years; 1278 of 2126 male [60.1%]); 12 studies (67%) were of high methodological quality. Eleven studies (1214 patients) evaluated disease progression and 7 (1162 patients) evaluated mortality. Elevated CCL5 levels were associated with reduced odds of unfavorable disease progression (OR, 0.78; 95% CI, 0.71-0.85; I2 = 0%) and mortality (OR, 0.65; 95% CI, 0.55-0.76; I2 = 23.1%). The protective association had significantly larger effect sizes for mortality than for disease progression (P = .047 for interaction). Subgroup analyses for disease progression demonstrated consistent protective associations without significant interaction by virus type (coronavirus: OR, 0.80 [95% CI, 0.70-0.90] vs noncoronavirus: OR, 0.74 [95% CI, 0.63-0.87]) or age group (pediatric: OR, 0.79 [95% CI, 0.69-0.90] vs adult: OR, 0.75 [95% CI, 0.63-0.88]). Results remained consistent in sensitivity analyses. Conclusions and relevance: In this systematic review and meta-analysis of 18 observational studies, elevated CCL5 levels were associated with favorable outcomes and survival in respiratory viral infections, reflecting a competent antiviral immune response rather than pathogenic hyperinflammation. These findings suggest that CCL5 may serve as a prognostic biomarker for risk stratification.
  • Item type: Publication ,
    Plasma biomarkers of immune regulation and senescence are associated with incident skeletal-related events in people with HIV: a case-cohort study.
    (Springer Nature, 2026-07-27) Pita-Martínez, Carlos; Rava, Marta; Virseda-Berdices, Ana; Martinez, Isidoro; Moreno, Santiago; Gómez Rodríguez, Carmen Elena; Armiñanzas, Carlos; Mena de Cea, Álvaro; Gisbert Pérez, Laura; Rodríguez-Rosado, Rafael; Jimenez-Sousa, Maria Angeles; Resino, Salvador; Martín-Escolano, Rubén; Instituto de Salud Carlos III; Agencia Estatal de Investigación (España); Centro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas); Ministerio de Ciencia, Innovación y Universidades (España); Comunidad de Madrid (España)
    Background: persistent immune dysregulation in people with HIV (PWH) on antiretroviral therapy (ART) contributes to an increased risk of skeletal-related events (SREs), serving as a critical paradigm for understanding accelerated aging and age-related diseases. We investigated the association between plasma biomarkers of immune regulation and senescence with incident SRE risk and evaluated potential effect modification by sex. Methods: in a case-cohort study nested within the Spanish CoRIS cohort (65 incident SRE cases; 252 subcohort, including 5 overlapping cases), we quantified 24 baseline biomarkers of immune checkpoints and senescence-associated secretory phenotype factors. We estimated adjusted hazard ratios (aHR) using Borgan II-weighted cause-specific Cox regression models adjusted for clinical confounders (age, region of origin, prior AIDS diagnosis, CD4 + T-cell count, coinfections, and lifestyle factors). Sex-biomarker interactions were assessed as exploratory endpoints. Results: nineteen biomarkers were independently associated with increased SRE risk (p < 0.05 & q < 0.10). Angiogenic factors (VEGF-A; aHR = 1.94; 95% CI, 1.40–2.68), immune checkpoints (PD-L2; aHR = 1.95; 95% CI, 1.09–3.49), and tissue remodeling markers (MMP-1; aHR = 1.91; 95% CI, 1.08–3.39) displayed independent associations, alongside consistent signals for TIM-3, PD-L1, and IL-8. Pairwise correlation analysis demonstrated clustering between checkpoints and inflammatory cytokines. Exploratory interaction analysis indicated that sex modified these associations; signals for seven markers (e.g., IL-1α, VEGF-A) were stronger in females, although the limited number of events warrants caution. Conclusions: circulating biomarkers of immune exhaustion, inflammation, and senescence are independently associated with incident SREs in PWH on long-term ART. Our findings indicate a systemic pro-inflammatory signature and suggest that females exhibit higher sensitivity to inflammatory damage.
  • Item type: Publication ,
    Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma.
    (Springer Nature, 2025-07-01) Sadaow, Lakkhana; Rodpai, Rutchanee; Smout, Michael J; Nakajima, Rie; Boonroumkaew, Patcharaporn; Sotillo, Javier; Tedla, Bemnet A; Luvira, Vor; Kitkhuandee, Amnat; Paonariang, Krisada; Sukeepaisarnjaroen, Wattana; Yamasaki, Hiroshi; Suttiprapa, Sutas; Laha, Thewarach; Sripa, Banchob; de Assis, Rafael; Jain, Aarti; Ittiprasert, Wannaporn; Mann, Victoria H; Wong, Yide; Felgner, Philip L; Maleewong, Wanchai; Brindley, Paul J; Loukas, Alex; Intapan, Pewpan M; National Research Council of Thailand; Khon Kaen University (Tailandia); NIH - National Cancer Institute (NCI) (Estados Unidos); National Health and Medical Research Council (Australia)
    Sensitive diagnostics are needed to improve management and surveillance of opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma (CCA) throughout East Asia. Herein we generate and screen an Opisthorchis viverrini recombinant secreted proteome to identity antibody biomarkers of liver fluke infection and CCA with sera from study participants in endemic populations and evaluate their utility as point-of-care immunochromatographic tests (PoC-ICTs). We incorporate two of the most promising antigens from the proteome array screen, P1 and P9, into PoC-ICTs to further validate their diagnostic performance. The P9-IgG4 PoC-ICT is superior amongst the single recombinant antigen tests for diagnosing fluke infection as well as fluke-induced CCA, and out-performs parasite crude extract-IgG ICTs. Here we identify two biomarkers of O. viverrini infection and infection-associated CCA that could form the basis of novel antibody serodiagnostic tests for human liver fluke infection and associated cancer.
  • Item type: Publication ,
    Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.
    (Taylor & Francis, 2021-06) Hernando Sebastian, Victoria; Cuevas, Maria Teresa; Perez-Olmeda, Mayte; Tasias, Maria; Vera, Mar; Jaen, Angels; Mena, Alvaro; Jarrin Vera, Inmaculada; Diaz Franco, Asuncion; CoRIS-HIV Biobank; Instituto de Salud Carlos III; Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
    Background: To estimate the prevalence of recent infection (RI) among people newly diagnosed with HIV in Spain using a representative sample collected by the AIDS Research Network cohort (CoRIS) during 2015-2016. Methods: Stratified sampling of CoRIS data was used with proportional allocation by mode of transmission of new HIV diagnoses notified to National Surveillance System. Samples used were from patients in the CoRIS cohort with available stored plasma collected within 6 months after diagnosis. Weighted methods were used to estimate the prevalence of RI and multivariate logistic regression models were used to determine associated factors. Results: Of the 669 individuals included, 55.1% were men who had sex with men (MSM), 24.6% were heterosexual, and 20.3% were non-MSM non-heterosexual. The weighted prevalence of RI was 11.8% (95% Confidence interval [CI] 9.4-14.8%) overall, 15.5% (12.2-19.4%) among MSM, 6.3% (3.9-10.0%) among heterosexual, and 8.6% (3.2-20.9%) in non-MSM non-heterosexual persons. Factors associated with prevalence of RI were: MSM (OR 2.05; 95% CI 1.02-4.14) vs. heterosexual, being Spanish (OR 2.92; 1.36-6.26) or European (OR 3.42; 1.28-9.13) vs. Latin American, having a secondary or higher education level (OR 3.08; 0.95-1.00) vs. primary, and having a CD4 count of 350-499 (OR 3.26; 1.46-7.30) or >500 (OR 6.26; 2.92-13.39) vs. <350 cells/mm3. Conclusions: In the absence of direct data from surveillance systems, the use of cohort data is a very valuable option for identifying the prevalence of RI at national level. This is the first nationwide study carried out in Spain to determine the prevalence of RI using an avidity assay.
  • Item type: Publication ,
    Comparison of three real-time polymerase chain reaction protocols for the diagnosis of imported schistosomiasis in a non-endemic setting.
    (Springer Nature, 2025-12-29) Martínez-Vallejo, Patricia; Silgado, Aroa; Mediavilla, Alejandro; Rubio Maturana, Carles; Zarzuela, Francesc; Muixí, Marc; Goterris, Lidia; Rodríguez-Pérez, Esther; Vázquez-Ávila, Sara; Salvador, Fernando; Oliveira-Souto, Inés; Molina, Israel; Serre-Delcor, Núria; Sotillo, Javier; Sulleiro, Elena
    Background: Schistosomiasis is a neglected tropical disease that mostly affects inhabitants of sub-Saharan Africa. With rising global migration, imported cases of schistosomiasis are increasingly being reported in non-endemic countries, where diagnosis is hindered by low parasite burdens and multiple Schistosoma species. Microscopy remains the gold standard, despite its limitations, whereas molecular techniques offer greater sensitivity. The aim of this study was to assess the performance of real-time polymerase chain reaction (PCR) protocols for the detection, at an international health centre in Barcelona, of imported cases of urogenital and intestinal schistosomiasis. Methods: This cross-sectional study included 75 adults from sub-Saharan Africa attending the Drassanes-Vall d'Hebron International Health Unit, Barcelona, between May 2023 and February 2024. Paired urine and stool samples were collected. Microscopy was performed on all samples. Urine was analysed by real-time PCR using the Dra1 target sequence. Stool was tested by three protocols targeting, respectively, Dra1, Sm1-7, and 28S rRNA. Schistosoma infection was confirmed by microscopic identification of eggs and/or parasite DNA detection by real-time PCR. Results: Schistosomiasis was confirmed in 12/75 patients (16%). Urogenital schistosomiasis was diagnosed in 3/75 cases; the performance values of real-time PCR in urine samples were not assessed. In stool, the pan-Schistosoma real-time PCR showed 55.6% sensitivity and 98.5% specificity, with a moderate agreement (κ = 0.631) with microscopy. The Sm1-7 assay fully matched microscopy for Schistosoma mansoni detection, and reached 100% sensitivity and specificity. A novel contribution of this study is the application of a real-time PCR assay targeting the Dra1 repetitive sequence in stool samples for the detection of Schistosoma intercalatum/Schistosoma guineensis. All of the microscopy-positive cases were real-time PCR positive, and one additional infection was detected by real-time PCR, which meant that 100% sensitivity and 98.6% specificity were achieved with this technique. Conclusions: Our findings underscore the need for accurate diagnostic tools for cases of imported schistosomiasis in non-endemic settings. Microscopy remains the reference standard, while the pan-Schistosoma real-time PCR showed limited sensitivity for stool samples. In contrast, the Sm1-7 and Dra1 assays demonstrated higher sensitivity and strong concordance with microscopy, with Dra1 also proving useful for the detection of S. intercalatum/S. guineensis in stool.
  • Item type: Publication ,
    Nippostrongylus brasiliensis and Heligmosomoides polygyrus exert anti-inflammatory effects through distinct immunomodulatory mechanisms in murine macrophages in vitro.
    (Springer Nature, 2026-08-26) Varea, Covadonga; Martin-Galiano, Antonio Javier; Vázquez-Ávila, Sara; Montero-Calle, Ana Maria; Cesteros, Julia; Perteguer-Prieto, Maria Jesus; Peláez-García, Alberto; Barderas Manchado, Rodrigo; García-Rodríguez, Juan José; Sotillo, Javier; Ministerio de Ciencia, Innovación y Universidades (España); Instituto de Salud Carlos III; Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
    Hookworm infections affect hundreds of millions of people worldwide and rank among the most significant neglected tropical diseases in terms of morbidity. Due to the inverse correlation between hookworm infection and the incidence of immune-mediated inflammatory diseases, considerable research has focused on understanding how parasitic helminths modulate host inflammation. Heligmosomoides polygyrus and Nippostrongylus brasiliensis are two hookworm-like rodent models widely used to investigate fundamental aspects of immune regulation. However, no comparative study has yet analysed the distinct immunological pathways activated by these helminths in their hosts. In this study, we compared cytokine profiles and M1/M2 macrophage polarization markers induced by H. polygyrus and N. brasiliensis, alongside proteomic pathways involved in their activation, using the RAW 264.7 murine macrophage cell line. H. polygyrus downregulated proinflammatory cytokines such as TNF-α and MCP-1, whereas N. brasiliensis did not affect TNF-α expression. Both parasites upregulated Th2 and regulatory cytokines, including IL-4 and TGF-β. Furthermore, H. polygyrus predominantly polarized macrophages toward an M2 phenotype, while N. brasiliensis maintained a balanced M1/M2 profile. Proteomic analysis revealed that N. brasiliensis and H. polygyrus exert their anti-inflammatory effects through distinct mechanisms, with N. brasiliensis acting via peripheral pathways and H. polygyrus via central regulatory mechanisms.
  • Item type: Publication ,
    Clinical significance of asymptomatic Leishmania infantum infection in people living with HIV_data set
    (Instituto de Salud Carlos III (ISCIII). Centro Nacional de Microbiología (CNM), 2026-09-10) Barbiero, Anna; Moreno, Javier; Bernardo, Lorena; Lozano-Rendal, Marina; Solana, Jose Carlos; Sanchez Herrero, Carmen; Marco Vinuesa, Arantxa; Cuenca, Paula; San Martín, Juan Víctor; Lagi, Filippo; Zammarchi, Lorenzo; Spinicci, Michele; Bartoloni, Alessandro; Granozzi, Bianca; Bacchiega, Michele; De Pascali, Alessandra Mistral; Balducelli, Emma; Ortalli, Margherita; Zaghi, Irene; Varani, Stefania; Carrillo, Eugenia
    This dataset contains demographic, clinical, immunological and molecular data from 204 people living with HIV (PLWH) recruited between 2013 and 2023 in Spain and Italy, all residing in Leishmania infantum-endemic areas. For each participant, the database includes age, sex, birthplace, cohort, CD4+ T-cell count, HIV viral load, antiretroviral treatment information, and the results of three complementary screening methods for asymptomatic Leishmania infection: kDNA real-time PCR, ELISA serology, and a whole blood stimulation assay (WBA) measuring parasite-specific cytokine responses (IFN-γ, IL-2 and IP-10). In addition, the dataset contains follow-up information for individuals with positive screening results, including repeated PCR, serological and immunological assessments and clinical monitoring for progression to visceral leishmaniasis. No cases of progression to overt VL were recorded during follow-up.
  • Item type: Publication ,
    Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants.
    (Wiley, 2025-05) García-García, María Luz; Alonso-López, Patricia; Alcolea, Sonia; Arroyas, M; Pozo Sanchez, Francisco; Casas Flecha, Inmaculada; Iglesias-Caballero, Maria; Sánchez-León, Rocío; Hurtado-Gallego, Jara; Calvo, Cristina
    Background: Nirsevimab, a monoclonal antibody providing passive immunity against RSV infections in infants, was introduced in Spain in October 2023 for children under 6 months and those born during the epidemic season. This study aimed to compare the clinical and virological characteristics of respiratory infections in hospitalized infants before and after nirsevimab introduction. Methods: We carried out a prospective study across two hospitals in Madrid during the 2022-2023 and 2023-2024 epidemic seasons. The study included infants under 12 months of age that were hospitalized with lower respiratory tract infections (LRTIs). Clinical, epidemiological, and virological data were analyzed and compared between the periods before and after the introduction of nirsevimab, as well as according to whether the infants had received this preventive treatment. Results: A total of 669 infants were included: 480 from October 2022 to March 2023 (S1) and 189 from October 2023 to March 2024 (S2). Respiratory infection-related admissions decreased by 62.5% in S2, with a 74.5% reduction in ICU admissions. RSV-related admissions decreased by 78%, HMPV by 36.6%, and adenovirus by 69.5%. Infants in S2 were older (p = 0.001) and had shorter hospital stays (p < 0.001) than in S1. Of 63 (33%) infants in S2 who received nirsevimab, 11 (17%) were diagnosed with RSV. High-flow oxygen use was less frequent among RSV patients treated with nirsevimab (p = 0.002). Conclusions: Nirsevimab introduction was significantly associated with reduced hospitalizations and severity of RSV and other respiratory infections. Its use was associated with fewer admissions and reduced need for intensive care, especially in RSV-infected infants but also in HMPV and adenovirus-infected infants.
  • Item type: Publication ,
    Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.
    (Oxford University Press, 2026-02-18) Iglesias-Caballero, Maria; Mas-Lloret, Vicente; Campoy, Albert; Calvo, Cristina; García, María Luz; Alcolea, Sonia; Moreno-Parrado, Laura; Reina, Jordi; Navascués, Ana; Antón, Andrés; Davina-Nunez, Carlos; Perez-Castro, Sonia; Costa, José; Fernández-González, Ana; Lepe, José Antonio; Gaona, Cristina; Pérez, Zulema; García-Martínez de Artola, Diego; Vázquez-Morón, Sonia; Camarero-Serrano, Sara; Cano, Olga; Pozo Sanchez, Francisco; Casas Flecha, Inmaculada; Instituto de Salud Carlos III; Unión Europea. Comisión Europea. Horizonte Europa
    Respiratory Syncytial Virus (RSV) is a leading cause of respiratory infections in infants and older adults. In Spain, surveillance is supported by the SiVIRA system and the RELECOV genomic sequencing network. The 2023-2024 season marked the first nationwide administration of nirsevimab, a monoclonal antibody for preventing severe RSV in infants. This study analyzes the genomic evolution of RSV during this period, focusing on potential escape mutations in the F protein. RSV-A showed high genetic diversity with eleven circulating lineages, while RSV-B was dominated by lineage B.D.E.1. Phylogenetic analysis revealed three distinct B.D.4.1.1 groups, one sharing mutations with B.D.E.1 in the nirsevimab binding site. Despite these changes, neutralization assays confirmed that nirsevimab and other monoclonal antibodies remained effective. No significant antigenic drift compromising immunoprophylaxis was observed. These findings support the continued efficacy of nirsevimab and highlight the importance of genomic surveillance for tracking RSV evolution and informing future immunization strategies.
  • Item type: Publication ,
    Second-season Impact of Nirsevimab: Clinical Outcomes of RSV Disease in Patients Immunized During Their First Season.
    (Wolters Kluwer, 2025-10-01) González-Bertolín, Isabel; Alcolea, Sonia; Alonso, Patricia; Arroyas, María; Fernández Castiella, Isabel; Echavarren, Iciar; Iglesias-Caballero, Maria; Casas Flecha, Inmaculada; García-García, María Luz; Calvo, Cristina; Instituto de Salud Carlos III; Unión Europea. Comisión Europea. Horizonte Europa; Merck, Sharp & Dohme
    Nirsevimab provides passive immunization against respiratory syncytial virus, yet concerns exist regarding its long-term impact. This study analyzed respiratory syncytial virus-associated lower respiratory tract infection severity in hospitalized children immunized with nirsevimab more than 6 months prior. No significant differences were found compared with nonimmunized children. Findings suggest no increased risk in the following season, supporting nirsevimab's safety as a preventive strategy.